Charles H. Nightingale, Paul G. Ambrose, George L. Drusano,'s Antimicrobial Pharmacodynamics in Theory and Clinical PDF

By Charles H. Nightingale, Paul G. Ambrose, George L. Drusano, Takeo Murakawa

ISBN-10: 0824729250

ISBN-13: 9780824729257

Show description

Read Online or Download Antimicrobial Pharmacodynamics in Theory and Clinical Practice, 2nd Edition PDF

Similar theory books

Marvin Perry, Howard E. Negrin (eds.)'s The Theory and Practice of Islamic Terrorism: An Anthology PDF

This can be the 1st anthology designed to reinforce the reader's figuring out of the a number of dimensions of Islamic terrorism by means of providing a cross-section of modern articles and choices from state of the art books at the topic.

Extra info for Antimicrobial Pharmacodynamics in Theory and Clinical Practice, 2nd Edition

Sample text

Source: From Ref. 17. 26 Mouton et al. the unbound fraction of the drug of around 100 for infections caused by gramnegative rods and 30 to 40 for Streptococcus pneumoniae, and that these values are consistent within the class of quinolones. Since the objective of treating patients is to treat them optimally, this translates in, when administering antimicrobials to a patient to treat an infection, the AUC of the antimicrobial administered in relation to the MIC of the microorganism causing the infection, a value of at least 100 for gram-negative rods.

Report from “the Norwegian Working Group on Antibiotics”. Scand J Infect Dis Suppl 1997; 103:1–36. Deutsches Institut fur Normung. DIN 58 940-10, Criteria for the Categorization of the In-Vitro Activity of Antimicrobial Agents. Beuth Verlag: Deutsches Institut fur Normung, 1990. Kahlmeter G, Brown DF, Goldstein FW, et al. European Committee on Antimicrobial Susceptibility Testing (EUCAST) technical notes on antimicrobial susceptibility testing. Clin Microbiol Infect 2006; 12(6):501–503. org Vogelman B, Craig WA.

Compared the results of MCSs of ceftazidime for three different populations: healthy volunteers, patients with cystic fibrosis, and intensive-care patients. Although there were differences at the extremes of the distribution, the general conclusion was similar for the patients and the volunteers. THE USE OF CART® ANALYSIS AND OTHER TOOLS TO DETERMINE THE PI SUSCEPTIBILITY BREAKPOINT VALUE The rate at which we are accumulating knowledge from analyses of PK–PD data derived from well-controlled clinical studies is accelerating.

Download PDF sample

Antimicrobial Pharmacodynamics in Theory and Clinical Practice, 2nd Edition by Charles H. Nightingale, Paul G. Ambrose, George L. Drusano, Takeo Murakawa


by James
4.4

Rated 4.68 of 5 – based on 9 votes